| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Anatomy (X.L., T.S., N.S., A.W., R.S., S.M.) and Physiology (E.N., W.Y., I.H., M.P.), Institute of Biomedicine, University of Turku, FIN-20520 Turku, Finland; and Unit for Preventive Nutrition (S.M.), Karolinska Institute NOVUM, S-14157 Huddinge, Sweden
Address all correspondence and requests for reprints to: Dr. Matti Poutanen, Department of Physiology, Institute of Biomedicine, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland. E-mail: matti.poutanen{at}utu.fi
Aromatization of androgens is a key step in estrogen production, and it regulates the delicate balance between estrogens and androgens in the gonads and sex steroid target tissues. In the present study, we generated transgenic mice (AROM+) bearing the human ubiquitin C promoter/human P450 aromatase fusion gene. AROM+ male mice are characterized by an imbalance in sex hormone metabolism, resulting in elevated serum E2 concentrations, combined with significantly reduced testosterone and FSH levels, and elevated levels of PRL and corticosterone. AROM+ males present a multitude of severe structural and functional alterations in the reproductive organs, such as cryptochidism associated with Leydig cell hyperplasia, dysmorphic seminiferous tubules, and disrupted spermatogenesis. The males also have small or rudimentary accessory sex glands with abnormal morphology; a prominent prostatic utricle with squamous epithelial metaplasia, and edema in the ejaculatory ducts and vas deferens. In addition, the abdominal muscle wall is thin, and the adrenal glands are enlarged, with cortical hyperplasia. Some of the abnormalities, such as undescended testes and undeveloped prostate, resemble those observed in animals exposed perinatally to high levels of exogenous estrogen, indicating that the elevated aromatase activity results in excessive estrogen exposure during early phases of development. Some of the disorders in the reproductive organs, furthermore, can be explained by the fact that AROM+ males are hypoandrogenic, and have elevated levels of serum PRL and corticosterone. Thus, the AROM+ mouse model provides a novel tool to investigate the consequences of a prolonged increase in conversion of androgens to estrogens which results in complex hormonal disturbances altering the structure and function of various male reproductive organs.
This article has been cited by other articles:
![]() |
S. Savolainen, T. Pakarainen, I. Huhtaniemi, M. Poutanen, and S. Makela Delay of Postnatal Maturation Sensitizes the Mouse Prostate to Testosterone-Induced Pronounced Hyperplasia: Protective Role of Estrogen Receptor-{beta} Am. J. Pathol., September 1, 2007; 171(3): 1013 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Carpino, V. Rago, V. Pezzi, C. Carani, and S. Ando Detection of aromatase and estrogen receptors (ER{alpha}, ER{beta}1, ER{beta}2) in human Leydig cell tumor Eur. J. Endocrinol., August 1, 2007; 157(2): 239 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Poutanen Toward understanding the endocrine regulation of gonadal somatic cells. Endocrinology, August 1, 2006; 147(8): 3662 - 3665. [Full Text] [PDF] |
||||
![]() |
L A Nolan and A Levy The effects of testosterone and oestrogen on gonadectomised and intact male rat anterior pituitary mitotic and apoptotic activity. J. Endocrinol., March 1, 2006; 188(3): 387 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, L. Strauss, A. Kaatrasalo, A. Mayerhofer, I. Huhtaniemi, R. Santti, S. Makela, and M. Poutanen Transgenic Mice Expressing P450 Aromatase as a Model for Male Infertility Associated with Chronic Inflammation in the Testis Endocrinology, March 1, 2006; 147(3): 1271 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Baines, M. O Nwagwu, E. C Furneaux, J. Stewart, J. B Kerr, T. M Mayhew, and F. J P Ebling Estrogenic induction of spermatogenesis in the hypogonadal (hpg) mouse: role of androgens Reproduction, November 1, 2005; 130(5): 643 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tiulpakov, N. Kalintchenko, T. Semitcheva, A. Polyakov, I. Dedov, P. Sverdlova, G. Kolesnikova, V. Peterkova, and P. Rubtsov A Potential Rearrangement between CYP19 and TRPM7 Genes on Chromosome 15q21.2 as a Cause of Aromatase Excess Syndrome J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4184 - 4190. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Yu, K. Fukamachi, K. W. Krausz, C. Cheung, and F. J. Gonzalez Potential Role for Human Cytochrome P450 3A4 in Estradiol Homeostasis Endocrinology, July 1, 2005; 146(7): 2911 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Shima, D. J. McLean, J. R. McCarrey, and M. D. Griswold The Murine Testicular Transcriptome: Characterizing Gene Expression in the Testis During the Progression of Spermatogenesis Biol Reprod, July 1, 2004; 71(1): 319 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Imamov, A. Morani, G.-J. Shim, Y. Omoto, C. Thulin-Andersson, M. Warner, and J.-A. Gustafsson Estrogen receptor {beta} regulates epithelial cellular differentiation in the mouse ventral prostate PNAS, June 22, 2004; 101(25): 9375 - 9380. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, L. Strauss, S. Makela, T. Streng, I. Huhtaniemi, R. Santti, and M. Poutanen Multiple Structural and Functional Abnormalities in the P450 Aromatase Expressing Transgenic Male Mice Are Ameliorated by a P450 Aromatase Inhibitor Am. J. Pathol., March 1, 2004; 164(3): 1039 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Meeks, T. A. Russell, B. Jeffs, I. Huhtaniemi, J. Weiss, and J. L. Jameson Leydig Cell-Specific Expression of DAX1 Improves Fertility of the Dax1-Deficient Mouse Biol Reprod, July 1, 2003; 69(1): 154 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ivell and S. Hartung The molecular basis of cryptorchidism Mol. Hum. Reprod., April 1, 2003; 9(4): 175 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, A. Warri, S. Makela, T. Ahonen, T. Streng, R. Santti, and M. Poutanen Mammary Gland Development in Transgenic Male Mice Expressing Human P450 Aromatase Endocrinology, October 1, 2002; 143(10): 4074 - 4083. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Burns and M. M. Matzuk Minireview: Genetic Models for the Study of Gonadotropin Actions Endocrinology, August 1, 2002; 143(8): 2823 - 2835. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Saarinen, R. Huovinen, A. Warri, S. I. Makela, L. Valentin-Blasini, R. Sjoholm, J. Ammala, R. Lehtila, C. Eckerman, Y. U. Collan, et al. Enterolactone Inhibits the Growth of 7,12-Dimethylbenz(a) anthracene-induced Mammary Carcinomas in the Rat Mol. Cancer Ther., August 1, 2002; 1(10): 869 - 876. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |